First Tracks Biotherapeutics, Inc.
TRAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002091349
In the last 90 days, First Tracks Biotherapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 150 institutions reported holding it in 13F filings for Q2 2026, worth $685.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in First Tracks Biotherapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 150
- +150 vs. Q1 2026
- Shares held
- 34.1M
- +34.1M vs. Q1 2026
- Total value
- $685.8M
- +$685.8M vs. Q1 2026
- New holders
- 150
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $685.8M |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding First Tracks Biotherapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 65,000 | $1.31M | 0.12% | +65,000 | New |
| Norges Bank | 69,100 | $1.39M | 0.00% | +69,100 | New |
| Bank of New York Mellon Corp | 69,813 | $1.40M | 0.00% | +69,813 | New |
| Invesco Ltd. | 71,014 | $1.43M | 0.00% | +71,014 | New |
| ADAR1 Capital Management, LLC | 71,910 | $1.45M | 0.07% | +71,910 | New |
| Financial Enhancement Group LLC | 74,450 | $1.50M | 0.18% | +74,450 | New |
| Nomura Asset Management International Inc. | 93,732 | $1.89M | 0.00% | +93,732 | New |
| Jain Global LLC | 98,956 | $1.99M | 0.02% | +98,956 | New |
| Ensign Peak Advisors, Inc | 115,978 | $2.33M | 0.00% | +115,978 | New |
| Rockefeller Capital Management L.P. | 116,939 | $2.35M | 0.00% | +116,939 | New |
| D. E. Shaw & Co., Inc. | 128,130 | $2.58M | 0.00% | +128,130 | New |
| Marshall Wace, LLP | 163,851 | $3.30M | 0.00% | +163,851 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 164,793 | $3.32M | 0.01% | +164,793 | New |
| Citadel Advisors LLC | 168,790 | $3.40M | 0.00% | +168,790 | New |
| Vanguard Fiduciary Trust Co | 191,220 | $3.85M | 0.00% | +191,220 | New |
| Ameriprise Financial Inc | 193,183 | $3.89M | 0.00% | +193,183 | New |
| Northern Trust Corp | 201,096 | $4.05M | 0.00% | +201,096 | New |
| Fred Alger Management, LLC | 218,400 | $4.39M | 0.01% | +218,400 | New |
| Apis Capital Advisors, LLC | 226,000 | $4.55M | 0.44% | +226,000 | New |
| Granahan Investment Management Inc | 238,304 | $4.79M | 0.17% | +238,304 | New |
| Nantahala Capital Management, LLC | 250,000 | $5.03M | 0.30% | +250,000 | New |
| Charles Schwab Investment Management Inc | 256,873 | $5.17M | 0.00% | +256,873 | New |
| Ally Bridge Group (NY) LLC | 284,287 | $5.72M | 7.37% | +284,287 | New |
| Federated Hermes, Inc. | 290,000 | $5.83M | 0.01% | +290,000 | New |
| Arrowstreet Capital, Limited Partnership | 299,500 | $6.03M | 0.00% | +299,500 | New |
| UBS Group AG | 310,886 | $6.26M | 0.00% | +310,886 | New |
| Point72 Asset Management, L.P. | 408,330 | $8.22M | 0.01% | +408,330 | New |
| Goldman Sachs Group Inc | 487,213 | $9.80M | 0.00% | +487,213 | New |
| Vanguard Portfolio Management LLC | 546,992 | $11.0M | 0.00% | +546,992 | New |
| Sofinnova Investments, Inc. | 565,199 | $11.4M | 0.61% | +565,199 | New |
| Palo Alto Investors LP | 603,489 | $12.1M | 1.68% | +603,489 | New |
| StemPoint Capital LP | 622,723 | $12.5M | 2.17% | +622,723 | New |
| Bank of America Corp | 647,962 | $13.0M | 0.00% | +647,962 | New |
| Geode Capital Management, LLC | 702,087 | $14.1M | 0.00% | +702,087 | New |
| Balyasny Asset Management LLC | 714,948 | $14.4M | 0.03% | +714,948 | New |
| Adage Capital Partners GP, L.L.C. | 729,000 | $14.7M | 0.02% | +729,000 | New |
| 683 Capital Management, LLC | 750,000 | $15.1M | 1.39% | +750,000 | New |
| Morgan Stanley | 781,534 | $15.7M | 0.00% | +781,534 | New |
| Sanofi | 821,917 | $16.5M | 3.10% | +821,917 | New |
| Woodline Partners LP | 917,176 | $18.5M | 0.06% | +917,176 | New |
| Vestal Point Capital, LP | 1,013,000 | $20.4M | 0.48% | +1,013,000 | New |
| Jupiter Topco LLC | 1,091,464 | $22.0M | 0.01% | +1,091,464 | New |
| Vanguard Capital Management LLC | 1,451,909 | $29.2M | 0.00% | +1,451,909 | New |
| State Street Corp | 1,512,896 | $30.4M | 0.00% | +1,512,896 | New |
| Trails Edge Capital Partners, LP | 1,514,000 | $30.5M | 4.84% | +1,514,000 | New |
| BlackRock, Inc. | 1,963,541 | $39.5M | 0.00% | +1,963,541 | New |
| Affinity Asset Advisors, LLC | 2,032,012 | $40.9M | 2.00% | +2,032,012 | New |
| FMR LLC | 2,054,127 | $41.3M | 0.00% | +2,054,127 | New |
| TCG Crossover Management, LLC | 2,895,304 | $58.3M | 1.40% | +2,895,304 | New |
| EcoR1 Capital, LLC | 3,174,519 | $63.9M | 3.17% | +3,174,519 | New |